JD Health InternationalJDHIF 90 Current Ratio is 2.72 as of Dec. 2025, which is 25% below its 10-year median of 3.65. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $10.42. The stock has 1 warning sign investors should review. Among 680 Healthcare Providers & Services companies, JD Health International ranks better than 74.41% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. JD Health International's current ratio for the quarter that ended in Dec. 2025 was 2.72.
JD Health International has a current ratio of 2.72. It generally indicates good short-term financial strength.
The historical rank and industry rank for JD Health International's Current Ratio or its related term are showing as below:
JDHIF'
s Current Ratio Range Over the Past 10 Years
Min: 2.71 Med: 3.65 Max: 9.12
Current: 2.72
During the past 9 years, JD Health International's highest Current Ratio was 9.12. The lowest was 2.71. And the median was 3.65.
JDHIF's Current Ratio is ranked better than 74.41% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs JDHIF: 2.72
JD Health International (OTCPK:JDHIF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
JD Health International Current Ratio Related Terms
JD Health International Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International Current Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Current Ratio distribution charts can be found below:
* The bar in red indicates where JD Health International's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International (JDHIF) has a Current Ratio of 2.72 as of Dec. 2025. This is 25% below median its historical median of 3.65. Over the past decade, JD Health International's Current Ratio has ranged from 2.71 to 9.12. According to the industry distribution chart, JD Health International ranks #174 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 25.6%.
Is JD Health International's Current Ratio too high?
JD Health International's current Current Ratio of 2.72 is 25% below median its 10-year median of 3.65. Over the past 10 years, this metric has ranged from a low of 2.71 to a high of 9.12. The Healthcare Providers & Services industry median Current Ratio is 1.47. JD Health International's value of 2.72 is 85% above this industry median. Based on the distribution chart, JD Health International ranks #174 out of 680 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's Current Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #174 out of 680 companies for Current Ratio. This puts JD Health International in the upper half of its industry. The industry median Current Ratio is 1.47. JD Health International's value of 2.72 is 85% above this benchmark. Historically, JD Health International's own Current Ratio has ranged from 2.71 to 9.12 over the past decade. While the company's 10-year median is 3.65 vs. the industry median of 1.47, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current Current Ratio of 2.72 is 85% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current Current Ratio is 2.72, which is 25% below median its own 10-year median of 3.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current Current Ratio of 2.72. The stock's GF Value™ is $10.42, compared to a current price of $5.85 — trading 43.9% below its estimated fair value. The current Current Ratio is 2.72, which is 25% below median its 10-year median of 3.65 and 85% above the Healthcare Providers & Services industry median of 1.47. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For JD Health International (JDHIF), the current Current Ratio is 2.72 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 43.9% below its estimated GF Value™ of $10.42.
Key valuation signals for JDHIF:
Current Ratio: 2.72 (25% below median its 10-year median of 3.65)
GF Value™: $10.42 vs. price of $5.85 (43.9% below fair value)
Industry Position: 85% above the Healthcare Providers & Services median (#174 of 680)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for JDHIF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
